Share on :

Asset Summary

Daily Performance Report for CRL ETF: Dec 26, 2024

Summary: The day started with CRL ETF opening at $188 and closing at $186.9. The ETF showed weakness throughout the day, with the highest price observed at $188 and the lowest at $186.8. The underlying asset had a trading range of $1.20 Overall, it was a negative trading day for CRL ETF, reflecting investor pessimism and market activity.

Change in Closing Price: There was a net decrease of $-1.10 or -0.59% in the closing price from the opening to the closing price over the day.

Volume Analysis: Trading volume for CRL ETF was 310 units during Dec 26, 2024, indicating active market participation and investor interest.

Opening Price: The day started at $188.

Highest Price: The highest price observed during the day was $188.

Lowest Price: The lowest price observed during the day was $186.8.

Closing Price: The day ended at $186.9.

Asset Performance Metrics and Risk Characteristics:

Understanding asset performance is crucial for evaluating investment quality and making informed decisions. Metrics like trailing return and drawdown provide insights into how an asset has performed over time, its volatility, and the efficiency of its returns relative to risk. Performance indicators help assess the stability, risk, and reward of an investment, allowing investors and portfolio managers to make comparisons and strategize accordingly.

Asset Technical Analysis

Technical analysis involves evaluating an asset's price and volume data to forecast future movements and make informed trading decisions. By using various technical indicators and chart patterns, investors can gain insights into market trends, price momentum, and potential turning points. This section delves into essential technical metrics, including moving averages, pivot points, and other indicators that provide a snapshot of an asset's current technical stance. Analyzing these indicators helps investors identify entry and exit points, assess market sentiment, and refine their trading strategies. Explore the following technical analysis data to understand the asset's performance dynamics and make better-informed decisions.

Moving Averages

Moving Averages are commonly used to smooth out price data and identify trends over a specific period. Here’s a summary of the latest moving averages for various periods:

  • SMA (Simple Moving Average): Reflects the average price over a specific number of periods.
  • EMA (Exponential Moving Average): Gives more weight to recent prices, making it more responsive to new information.
  • WMA (Weighted Moving Average): Assigns a weight to each price, emphasizing more recent prices.
  • WEMA (Weighted Exponential Moving Average): Combines elements of both WMA and EMA for a more responsive moving average.

Supercharge Your CRL Trading Now

Elevate your trading strategy with Rankmytrade’s sophisticated tools for CRL. Our system integrates cutting-edge technology and expert analysis to support your investment goals. Enhance your market performance today and explore the benefits of advanced trading now!

Experience Excellence Now

Frequently Asked Questions

CRL stock performance can vary; consult financial news outlets for the latest updates and market analysis.

News can be found on financial news websites, Charles River Laboratories’ investor relations page, and industry-specific publications.

Charles River Laboratories does not currently pay dividends, focusing on reinvesting in growth opportunities.

Competitors include Covance, WuXi AppTec, and Charles River’s other service providers in the life sciences sector.

Analysts provide insights based on market trends and financial reports; check recent analyst reports for evaluations.

Consider risks such as changes in healthcare regulations, market competition, and dependency on the pharmaceutical sector.

To determine if CRL is a good long-term investment, consider industry trends, financial health, and growth potential.

Charles River regularly evaluates opportunities for expansion and innovation; stay updated through their press releases and earnings calls.

Factors include industry demand for preclinical and clinical services, regulatory changes, and overall market conditions.

You can track CRL stock performance through brokerage platforms, financial news websites, and stock market apps.

Supercharge Your CRL Trading Now

Elevate your trading strategy with Rank My Trade Platform’s sophisticated tools for CRL. Our system integrates cutting-edge technology and expert analysis to support your investment goals. Start optimizing your trades today and explore the benefits of advanced trading now!

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. RankMyTrade (RMT) has not independently verified this data and does not guarantee its accuracy. The information and calculations provided by RankMyTrade are for educational and informational purposes only and should not be construed as financial or investment advice.

With any investment, your capital is at risk. The value of your portfolio go down as well as up. Past performance is no guarantee of future results. By using this website, you accept our Terms of Service, Privacy Policy, and Payment Agreement.

Market data is provided in near real-time when available, but we do not guarantee its accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind. Unless otherwise noted, RankMyTrade and its affiliates are not partners, affiliates, or licensees of these companies.

Supported Assets & ETFs